Topics

Hematologic diseases

Pharmacology Consensus statement 17 June 2019 Free

Diagnosis and management of heparin‐induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group

These are the first Australasian recommendations for diagnosis and management of HIT, with a focus on locally available diagnostic assays and therapeutic options

Joanne Joseph · David Rabbolini · Anoop K Enjeti · Emmanuel Favaloro · Marie‐Christine Kopp · Simon McRae · Leonardo Pasalic · Chee Wee Tan · Christopher M Ward · Beng H Chong

Mja2 50213
Hematologic diseases Guideline summary 11 February 2019 Free

New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism

The THANZ guideline for the diagnosis and management of VTE has been developed by the VTE Working Group based on up‐to‐date evidence and using an evidence‐based approach. The guideline aims to promote optimal management of VTE. The extended version of the guideline can be found on the THANZ website (www.thanz.org.au/resources/thanz-guidelines).

Huyen A Tran · Harry Gibbs · Eileen Merriman · Jennifer L Curnow · Laura Young · Ashwini Bennett · Chee Wee Tan · Sanjeev D Chunilal · Chris M Ward · Ross Baker · Harshal Nandurkar

Mja2 50004
General medicine Guideline summary 2 August 2018 Open Access

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018

Atrial fibrillation is increasing in prevalence and associated with significant morbidity and mortality

David Brieger · John Amerena · John R Attia · Beata Bajorek · Kim H Chan · Cia Connell · Ben Freedman · Caleb Ferguson · Tanya Hall · Haris M Haqqani · Jeroen Hendriks · Charlotte M Hespe · Joseph Hung · Jonathan M Kalman · Prashanthan Sanders · John Worthington · Tristan Yan · Nicholas A Zwar

18 00646
Hematologic diseases Letters 5 February 2018 Free

Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus

To the Editor: I found the article by Kiely and colleagues1 very interesting. The authors concluded that “it should be noted that a relatively small number of imported ZIKV [Zika virus] infections have been reported in Australia, there have been no reported cases of local ZIKV transmission, and the geographical distribution of the potential ZIKV mosquito vector in Australia (Aedes aegypti) is limited to northern Queensland,” and that “at present, ZIKV represents a low risk to blood safety in Australia.”1 Indeed, Kiely and colleagues may be correct in their statement. Nevertheless, without supportive evidence, it seems too soon to draw a conclusion. The estimation of the risk or possibility of transfusion-transmitted ZIKV infection in each setting may be based on mathematical modelling with reference to risk of transmission of other arboviruses in that setting. A good example is the previous report on the estimated risk of transfusion-transmitted ZIKV infection in Thailand.2 However, the lack of reports on ZIKV transmission does not mean that the problem does not exist; many patients with ZIKV infection are asymptomatic and can be easily missed.3

Viroj Wiwanitkit

Dermatology Medical education 16 October 2017 Free

Livedo racemosa

A 30-year-old woman presented with progressive, symmetrical, jagged and reticulate erythema and hyperpigmentation of the lower legs consistent with livedo racemosa

Deshan F Sebaratnam · Nita Agar

16 01355

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.